HTA Database - Search Results

Sort by Relevance

Search Results [1488 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2015	NIHR Health Technology Assessment programme	The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study
2015	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry. Part III: carnitine uptake deficiency (CUD); short-chain acyl-CoA dehydrogenase deficiency (SCADD); very long-chain acyl-CoA dehydrogenase deficiency (VLCADD)]
2015	NIHR Health Services and Delivery Research programme	Translation into British Sign Language and validation of the Strengths and Difficulties Questionnaire
2015	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry. Part IV: Beta-kethiolase deficiency (BKT); 3-Hydroxy-3-methyl glutaric aciduria (HMG)]
2015	Agency for Healthcare Research and Quality (AHRQ)	Routine iron supplementation and screening for iron deficiency anemia in children ages 6 to 24 months: a systematic review to update the U.S. Preventive Services Task Force Recommendation
2015	Health Council of the Netherlands Gezondheidsraad (GR)	Checking checked: appropriate use of health checks
2015	Health Council of the Netherlands Gezondheidsraad (GR)	Neonatal screening: new recommendations
2015	Health Council of the Netherlands Gezondheidsraad (GR)	Population Screening Act: study of faecal tests within the population based screening programme for colorectal cancer
2015	Agency for Healthcare Research and Quality (AHRQ)	Routine iron supplementation and screening for iron deficiency anemia in pregnant women
2015	Health Quality Ontario (HQO)	Prostate-Specific Antigen (PSA)–based population screening for prostate cancer: an evidence-based analysis
2015	Health Quality Ontario (HQO)	Harms of Prostate-Specific Antigen (PSA) screening in prostate cancer: a rapid review
2015	Health Quality Ontario (HQO)	Prostate-Specific Antigen (PSA)–based population screening for prostate cancer: an economic analysis
2015	Belgian Health Care Knowledge Centre (KCE)	Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening
2015	Belgian Health Care Knowledge Centre (KCE)	Cardiovascular pre-participation screening in young athletes
2015	Belgian Health Care Knowledge Centre (KCE)	What are the recommended clinical assessment and screening tests during pregnancy?
2015	Belgian Health Care Knowledge Centre (KCE)	Oncogenetic testing for persons with hereditary endocrine cancer syndromes
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Panel antibody detection for idiopathic inflammatory myopathies]
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Assessment on nucleic acid amplification techniques (NAT) for human immunodeficiency, hepatitis C and hepatitis B virus screening in blood banks]
2015	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry. Part IV: β-ketothiolase deficiency (BKT); 3-hydroxy-3-methyl glutaric aciduria (HMG)]
2015	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Economic evaluation of different strategies for screening for Chagas' disease in Spain]
2015	Health Quality Ontario (HQO)	Colon capsule endoscopy for the detection of colorectal polyps: OHTAC Recommendation
2015	Health Council of the Netherlands Gezondheidsraad (GR)	Population Screening Act: risk stratification based on familial risk of bowel cancer
2015	Health Council of the Netherlands Gezondheidsraad (GR)	[Population Screening Act: prevalence of gastrointestinal tract disorders studied with a video capsule]
2015	Agency for Healthcare Research and Quality (AHRQ)	Screening for speech and language delays and disorders in children age 5 years or younger: a systematic review for the U.S. Preventive Services Task Force
2015	HAYES, Inc.	Digital breast tomosynthesis for breast cancer diagnosis and screening
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Vitamin D screening in adults]
2015	Health Information and Quality Authority (HIQA)	Health technology assessment (HTA) of a national screening programme for atrial fibrillation in primary care
2015	HAYES, Inc.	Full-field digital mammography for breast cancer screening
2015	Haute Autorite de sante (HAS)	[Interferon-gamma release assays as in vitro screening tests for latent tuberculosis infection]
2015	Haute Autorite de sante (HAS)	[Modification of the nomenclature of procedures in laboratory medicine for research into Treponema pallidum (bacteria responsible for syphilis)]
2015	Malaysian Health Technology Assessment (MaHTAS)	Capsule endoscopy for colorectal cancer (CRC) screening
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Rapid Rhythm ECG for atrial fibrillation
2015	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Opportunities and strategies to drive appropriate use of MRI in Austria. Part 2]
2015	Andalusian Health Technology Assessment Area (AETSA)	Utility of QF_PCR in prenatal diagnosis of fetal aneuploidies
2015	Adelaide Health Technology Assessment (AHTA)	National Evidence-Based Guideline on Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes: Technical Report
2015	Adelaide Health Technology Assessment (AHTA)	Screening for coronary artery disease using CT calcium scoring
2015	Adelaide Health Technology Assessment (AHTA)	Blood and stool biomarker testing for colorectal cancer screening
2015	Adelaide Health Technology Assessment (AHTA)	Circulating tumour DNA assays
2015	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Screening for asymptomatic bacteriuria within the framework of the German maternity guidelines, under special consideration of test methods]
2015	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Newborn screening for critical congenital heart disease using pulse oximetry]
2015	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Invitation and fact sheet for breast cancer Screening - Rapid report]
2015	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ultrasound screening for abdominal aortic aneurysms]
2015	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Screening for visual impairment in children younger than 6 years - rapid report]
2015	Canary Health Service	[Cost-effectiveness of neonatal screening for 3-hydroxy-3-methylglutaric aciduria (HMG)]
2015	Canary Health Service	[Effectiveness, safety and cost-effectiveness of cholecystectomy versus conservative treatment for uncomplicated symptomatic cholelithiasis or acute cholecystitis]
2014	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds
2014	NIHR Health Technology Assessment programme	A modelled analysis using data from the ARTISTIC trial of the potential effectiveness and cost-effectiveness of HPV testing in cervical cancer screening
2014	NIHR Health Technology Assessment programme	Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment -systematic review and modelling of progression and cost-effectiveness
2014	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical effectiveness of newborn screening for inborn errors of metabolism. Part II: Methylmalonic acidemia, Propionic acidemia, Tyrosinemia type I]
2014	Agency for Healthcare Research and Quality (AHRQ)	Primary care screening for abdominal aortic aneurysm: a systematic evidence review for the U.S. preventive services task force
2014	HAYES, Inc.	PTEN gene expression testing in Non-Small Cell Lung Cancer (NSCLC)
2014	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of brief intervention for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trial (SHEAR)
2014	Agency for Healthcare Research and Quality (AHRQ)	Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: systematic review to update the U.S. preventive services task force recommendation
2014	NIHR Horizon Scanning Centre (NIHR HSC)	BreathLink™ for breast cancer screening
2014	Health Quality Ontario (HQO)	Preoperative resting echocardiography for noncardiac surgery
2014	Health Quality Ontario (HQO)	Preoperative cardiac stress tests for noncardiac surgery
2014	Health Quality Ontario (HQO)	Preoperative consultations
2014	Agency for Healthcare Research and Quality (AHRQ)	Screening for hepatitis B virus infection in nonpregnant adolescents and adults: systematic review to update the 2004 U.S. Preventive Services Task Force Recommendation
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Population-based colorectal cancer screening: guidelines
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Vancomycin-resistant enterococci isolation and screening strategies: clinical evidence and cost-effectiveness
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Non-invasive prenatal testing: a review of the cost effectiveness and guidelines
2014	Blue Cross Blue Shield Association (BCBS)	Use of digital breast tomosynthesis with mammography for breast cancer screening or diagnosis
2014	Blue Cross Blue Shield Association (BCBS)	Special report: screening asymptomatic women with dense breasts and normal mammograms for breast cancer
2014	Health Council of the Netherlands Gezondheidsraad (GR)	Population screening for breast cancer: expectations and developments
2014	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Neonatal screening for classic galactosemia. Systematic review]
2014	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Newborn screening for congenital adrenal hyperplasia. Systematic Review]
2014	HAYES, Inc.	Alpha-1 antitrypsin deficiency (AATD)
2014	HAYES, Inc.	Hereditary paraganglioma (PGL)/pheochromocytoma (PCC) syndromes
2014	HAYES, Inc.	PCA3 detection test for prostate cancer
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Digital Breast Tomosynthesis]
2014	Institute of Health Economics (IHE)	Effectiveness of screening for endemic antibiotic resistant organisms (AROs) in hospital settings
2014	Agency for Healthcare Research and Quality (AHRQ)	Screening for asymptomatic carotid artery stenosis: a systematic review and meta-analysis for the U.S. Preventive Services Task Force
2014	National Evidence-based Healthcare Collaborating Agency (NECA)	[Cost-effectiveness of conventional cytology and HPV DNA testing for cervical cancer screening in South Korea]
2014	Agency for Healthcare Research and Quality (AHRQ)	Imaging tests for the diagnosis and staging of pancreatic adenocarcinoma
2014	Belgian Health Care Knowledge Centre (KCE)	A decision aid for an informed choice when patient asks for PSA screening
2014	Belgian Health Care Knowledge Centre (KCE)	Informed choice on breast cancer screening: messages to support informed decision
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Cologuard® for colorectal cancer screening
2014	HAYES, Inc.	OVA1 ovarian tumor triage test
2014	NIHR Health Technology Assessment programme	Assessing the risk of self-harm in an adult offender population: an incidence cohort study
2014	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Neonatal screening for biotinidase deficiency]
2014	Agency for Healthcare Research and Quality (AHRQ)	Screening for gonorrhea and chlamydia: systematic review to update the U.S. Preventive Services Task Force Recommendations
2014	Blue Cross Blue Shield Association (BCBS)	Fecal DNA analysis for colorectal cancer screening
2014	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Economic evaluation of preimplantation genetic diagnosis (PGD) for screening]
2014	Agency for Healthcare Research and Quality (AHRQ)	Decision aids for cancer screening and treatment
2014	Adelaide Health Technology Assessment (AHTA)	Bone mineral density analyses using dual energy x-ray absorptiometry (DXA) for women in their 50th year
2014	Adelaide Health Technology Assessment (AHTA)	Retinal photography with a non-mydriatic retinal camera in people with diabetes
2014	HAYES, Inc.	Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening
2014	HAYES, Inc.	Digital breast tomosynthesis for breast cancer diagnosis and screening
2014	HAYES, Inc.	High-resolution anoscopy for the evaluation of anal lesions
2014	HAYES, Inc.	Cologuard
2014	HAYES, Inc.	Genetic testing for Lynch syndrome
2014	HAYES, Inc.	Screening for Lynch syndrome
2014	Agency for Healthcare Research and Quality (AHRQ)	Screening for vitamin D deficiency: systematic review for the U.S. Preventive Services Task Force Recommendation
2014	Agency for Healthcare Research and Quality (AHRQ)	Screening for high blood pressure in adults: a systematic evidence review for the U.S. Preventive Services Task Force
2014	Medical Services Advisory Committee (MSAC)	National Cervical Screening Program renewal
2014	Medical Services Advisory Committee (MSAC)	Review of interim funded service: breast Magnetic Resonance Imaging (MRI)
2014	Health Council of the Netherlands Gezondheidsraad (GR)	Population Screening Act: first trimester scan for prenatal screening
2014	Health Council of the Netherlands Gezondheidsraad (GR)	Population screening act: study into self-sampling as primary screening for cervical cancer
2014	Institute of Health Economics (IHE)	Low dose computed tomography for the screening of lung cancer in adults
2014	Institute of Health Economics (IHE)	First and second trimester prenatal screening update